
Botox for headaches is not a treatment for every type of headache. In the UK, BOTOX has a licensed medical use for preventing headaches in selected adults with chronic migraine. The treatment follows a specific head and neck injection protocol and is different from having cosmetic Botox in areas such as the forehead or frown lines.
Chronic migraine means having headaches on at least 15 days each month, with migraine features on at least 8 of those days, for more than three months. Whether Botox should be considered depends on your diagnosis, previous preventive treatments, medication use and an individual medical assessment.
If you have frequent headaches without a diagnosis, or your usual headache pattern has changed, medical assessment should come before comparing injectable treatments.
If you first want to understand the treatment itself, read more about Botox.

If you do not know why you are having frequent headaches, start with medical assessment rather than Botox treatment. The same applies when a previously familiar headache pattern changes significantly.
Contact an appropriate healthcare professional if headaches are becoming more frequent, are substantially affecting everyday activities, or you are increasingly relying on painkillers or migraine medication.
Seek urgent medical assessment for a sudden very severe headache or a headache accompanied by new problems with speech, vision, strength, sensation, severe confusion or other significant neurological symptoms.
Headaches that begin following a head injury or occur with serious systemic symptoms also need appropriate medical assessment.
Botulinum toxin type A may be considered for some adults with chronic migraine after other preventive treatment options have been tried.
NICE defines chronic migraine as headaches on at least 15 days each month, with migraine on at least 8 of those days.
For treatment under the NICE criteria, at least three preventive medicines must have either:
not worked;
not been tolerated; or
been unsuitable because of safety concerns.
Medication overuse must also be appropriately managed.
These criteria do not mean that everyone who meets the headache-day threshold should have Botox. A headache specialist or appropriately qualified healthcare professional assesses your diagnosis, previous treatment, medication use and individual medical circumstances.
A headache diary is often useful because it provides a record of headache days, migraine days and changes over time.
The licensed BOTOX treatment for chronic migraine is a medical protocol involving multiple injection sites across specific muscles of the head and neck.
The UK product information describes a total dose of 155 to 195 Allergan Units divided across 31 to 39 injection sites in seven head and neck muscle areas. The recommended treatment interval is normally 12 weeks.
A cosmetic Botox zone is different. A zone is a commercial way of describing an aesthetic treatment area such as the frown lines or forehead. One cosmetic zone, or several cosmetic zones, should not be treated as equivalent to the chronic migraine protocol.
The units used for BOTOX are product-specific. Units from different botulinum toxin products should not be assumed to be interchangeable.
Read more about what a Botox zone means if you want to understand this distinction.
The migraine protocol uses multiple injection sites rather than one single painful area.
The licensed protocol distributes injections across seven head and neck muscle areas. These include areas around the forehead and temples as well as the back of the head, neck and upper shoulder region.
The standard protocol contains 31 injection sites, with additional sites possible within specified muscle groups up to a total of 39 when clinically appropriate.
The exact treatment plan is determined by the healthcare professional. The purpose is prevention of chronic migraine, not cosmetic correction of individual facial areas.
Botulinum toxin type A temporarily affects signalling at nerve endings. Its role in chronic migraine is not explained simply by relaxing tense muscles; the preventive effect is also thought to involve changes in pain signalling.
This is why migraine Botox is administered according to a defined head and neck protocol rather than only into whichever muscle feels tense.
The treatment does not cure migraine, and response varies between individuals.
For a broader explanation of the medicine, read how Botox works.
Botox for chronic migraine does not provide an immediate result. Changes may become noticeable over the following weeks, and treatment response is usually assessed using a headache diary rather than how you feel on the treatment day alone.
You may notice local tenderness, redness, swelling or bruising around some injection sites. Migraine prevention should not be judged immediately after the injections.
Continue recording headache days, migraine days and relevant medication use. This provides a clearer comparison with your pattern before treatment.
The licensed BOTOX protocol recommends treatment at 12-week intervals when further treatment is appropriate.
NICE recommends stopping botulinum toxin type A when headache days have not reduced by at least 30% after two treatment cycles.
Treatment should also be stopped under the NICE criteria when chronic migraine has changed to episodic migraine — fewer than 15 headache days per month — for three consecutive months.
Not responding sufficiently does not mean that more cosmetic Botox should simply be added. The diagnosis, treatment response and next preventive options should be reviewed appropriately.
Read more about possible reasons Botox does not work as expected.
Possible effects after treatment include injection-site pain or bruising, neck pain, muscle pain or stiffness, temporary muscle weakness, eyelid drooping and temporary worsening of headache or migraine. The type, severity and duration of side effects vary between individuals.
BOTOX is contraindicated in people with known hypersensitivity to botulinum toxin type A or relevant ingredients and when there is an infection at a proposed injection site. Certain neurological or neuromuscular conditions require additional specialist caution. Tell the treating healthcare professional about your medical history, medicines and previous reactions before treatment.
Current UK BOTOX product information does not recommend use during pregnancy. Use during breastfeeding also cannot currently be recommended because sufficient information is not available. Discuss your circumstances with the healthcare professional responsible for your migraine care.
Seek immediate medical advice if swallowing, speaking or breathing difficulties develop after botulinum toxin treatment. Serious or rapidly worsening unexpected symptoms also require medical assessment.
For more detailed safety information, read about possible Botox treatment complications.
NHS access to Botox for chronic migraine depends on the clinical criteria and the specialist pathway where you live.
In England and Wales, NICE recommends botulinum toxin type A as an option for adults with chronic migraine when at least three preventive medicines have not worked, are not tolerated or are unsuitable because of safety concerns, and medication overuse has been appropriately managed.
Meeting these criteria does not automatically mean treatment will be provided. A specialist service still needs to assess whether it is clinically appropriate in your circumstances.
Pathways and service availability can differ across the UK. Your GP or headache service can explain the relevant local referral route.
If you are comparing NHS funding, private treatment or other payment routes, see the separate information about Botox reimbursement and costs.
Private prices are only meaningful when the treatment being priced is clear. A low cosmetic price for one Botox zone is not comparable with a full chronic migraine protocol involving multiple head and neck injection sites.
Before comparing private prices, check what the quoted amount includes, such as:
the medical assessment;
the BOTOX product and dose;
the migraine treatment protocol;
follow-up or treatment review;
whether the price refers to one treatment cycle.
Injectablesbooking does not currently use a general cosmetic Botox zone price as a substitute for the cost of a chronic migraine protocol.
For broader pricing information, see Botox costs.
If you are considering private treatment, first confirm that the provider offers assessment and treatment specifically for chronic migraine rather than only cosmetic Botox.
Ask how chronic migraine is assessed and whether your headache pattern and previous preventive treatment are reviewed before injections are proposed.
A professional title alone does not show how much experience someone has treating chronic migraine. Ask about relevant headache and migraine treatment experience.
Confirm whether the proposed treatment follows an appropriate medical migraine protocol rather than a package of cosmetic Botox zones.
Ask how headache days and treatment response are reviewed and what happens if you experience unexpected symptoms or insufficient improvement.
A repeat treatment should be based on clinical assessment and response, not simply an automatic cosmetic maintenance schedule.
You can also read what to consider when choosing a Botox practitioner.







Botox is not used for every type of headache. BOTOX has a licensed preventive use in selected adults with chronic migraine, which means at least 15 headache days per month with migraine on at least 8 of those days.
Under NICE criteria, adults with chronic migraine may be considered when at least three preventive medicines have not worked, are not tolerated or are unsuitable because of safety concerns, and medication overuse has been appropriately managed. Individual assessment is still required.
The licensed BOTOX protocol uses 31 to 39 injection sites across specified areas of the head and neck. The UK product information specifies a total dose of 155 to 195 Allergan Units.
The protocol distributes injections across seven head and neck muscle areas, including regions around the forehead, temples, back of the head, neck and upper shoulders. The exact treatment plan is determined by the healthcare professional.
The recommended BOTOX re-treatment schedule for chronic migraine is every 12 weeks when continued treatment is medically appropriate.
The effect is not immediate. Changes may become apparent over the following weeks, and response is assessed over treatment cycles using measures such as headache days and a headache diary.
NICE recommends stopping treatment when headache days have not reduced by at least 30% after two treatment cycles. The diagnosis, response and other preventive options can then be reviewed with the healthcare team.
No. Cosmetic forehead Botox treats a limited aesthetic area. The licensed chronic migraine protocol uses multiple injection sites across specified areas of the head and neck and a defined product-specific dose.
BOTOX has not shown efficacy for preventing headaches in episodic migraine, where there are fewer than 15 headache days per month. The licensed headache indication is for chronic migraine.
It may be available through specialist NHS care when the relevant clinical criteria are met, but referral pathways and availability differ across the UK. A GP or specialist headache service can explain the route that applies locally.
Search, compare and book a injectable or filler treatment
Injectablesbooking.co.uk part of Halftien BV
info@injectablesbooking.co.uk
KVK: 81484879
BTW: NL862111808B01